Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6EYF

Butyrylcolinesterase expressed in CHO cells co-crystallised with a rivastigmine analogue

Replaces:  6EUL
Summary for 6EYF
Entry DOI10.2210/pdb6eyf/pdb
DescriptorCholinesterase, 2-acetamido-2-deoxy-beta-D-glucopyranose, [3-[(1~{R})-1-(dimethylamino)ethyl]-4-oxidanyl-phenyl] ~{N}-ethyl-~{N}-methyl-carbamate, ... (6 entities in total)
Functional Keywordsbutyrylcholinesterase, alzheimer disease, organophosphate, carbamylated, rivastigmine analogue, rational design, hydrolase
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains1
Total formula weight61113.92
Authors
Brazzolotto, X.,De la Mora, E.,Dighe, S.,Ross, B. (deposition date: 2017-11-12, release date: 2018-11-21, Last modification date: 2024-01-17)
Primary citationDighe, S.,De la Mora, E.,Chan, S.,Kantham, S.,McColl, G.,Veliyath, S.K.,Miles, J.A.,Nessar, Z.Y.,Mcgeary, R.,Silman, I.,Weik, I.,Parat, M.O.,Brazzolotto, X.,Ross, B.
Rivastigmine and metabolite analogues with putative Alzheimer's disease-modifying properties in a Caenorhabditis elegans model
Commun Chem, 2019
Cited by
DOI: 10.1038/s42004-019-0133-4
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon